NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Cancer Vaccine Week


Susan Hasty, Publisher
Table of Contents . . . March 16th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Cancer Vaccine Week | Other Publications

Cancer Vaccines - New cancer vaccines study findings have been published by X.X. Song and colleagues

Cancer Vaccines - Reports from Hebrew University highlight recent research in cancer vaccines

Cancer Vaccines - Data on cancer vaccines published by researchers at University of Virginia, Department of Surgery

Cancer Vaccines Therapy - Researchers from University of Pittsburgh, Department of Pathology describe findings in cancer vaccines therapy

Immunization - Researchers from National Institutes of Health publish findings in immunization

Melanoma Vaccines - College of Medicine details research in melanoma vaccines

Cancer Vaccines - IDRI Announces Appointment of Dr. Karen Auditore-Hargreaves as SVP, Scientific Affairs

Research and Markets - Analytical Tool - Cancer Vaccines

Therapy - Pharmexa and Affitech to Combine Operations to Create a New Antibody Therapeutics Company



Return to Top of Page

-----------------------
PR Login